Cyclosporine for AIHA

Overview
Cyclosporine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to prevent the rejection of transplanted organs. Cyclosporine is also used off-label to treat autoimmune hemolytic anemia. Cyclosporine is sold under the brand names Gengraf, Neoral, and Sandimmune.

Cyclosporine is a disease-modifying antirheumatic drug (DMARD), a type of medication that suppresses the immune system and fights inflammation. Cyclosporine is believed to work by limiting the activity of immune cells that contribute to inflammation.

How do I take it?
Cyclosporine comes in capsule and oral solution forms. Take cyclosporine as prescribed, usually once or twice a day.

Side effects
According to the FDA, common side effects of cyclosporine include headache, acne, flushing, depression, insomnia, ear problems, pain or pressure in the face, tingling or burning in the extremities, increased hair growth, tremors, increased gum tissue growth, muscle or joint pain, growth of breast tissue in men, gas, heartburn, and diarrhea.

Rare but serious side effects listed for cyclosporine include kidney damage, high blood pressure, and increased risk for some types of cancer (including skin cancer).

For more details about this treatment, visit:

Cyclosporine — MedlinePlus
https://medlineplus.gov/druginfo/meds/a601207.html

Treatment of Autoimmune Hemolytic Anemias — Haematologica
https://www.haematologica.org/article/view/7163